LYNPARZA® (olaparib) Receives Three New Approvals in Japan

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. SPY
2. MDT
3. ENOV
4. AON
5. AZN
6. BLSM
7. GRMN
8. VRSK
9. YUM
10. TXNM

Go back to LYNPARZA® (olaparib) Receives Three New Approvals in Japan
Merck & Co. (NYSE: MRK) Delayed: 149.45 +1.69 (1.14%)
Previous Close $147.76    52 Week High $65.46 
Open $150.23    52 Week Low $47.97 
Day High $151.68    P/E 101.67 
Day Low $149.16    EPS $1.47 
Volume 861,863